TRACE
Department of Psychiatry and Psychotherapy

DepressionDC

DOI: 10.1016/S0140-6736(23)00640-2
Added to TRACE
2025-09-22
Team
2 members
Project contacts are listed beside the study content.

From the dashboard

Groups

  • shamtdcs 77
  • activetdcs 83

Number per category. Aggregated data only. Data as of 2026-11-13.

Study Overview

Description

The DepressionDC trial was a triple-blind, randomised controlled trial that investigated the efficacy of transcranial direct current stimulation (tDCS) versus sham stimulation as an additional treatment to a stable dose of selective serotonin reuptake inhibitors (SSRIs) in adults with major depressive disorder (MDD).

Study Design

Depression DC trial was conducted at eight hospitals in Germany. Participants aged between 18-65 years were eligible if they had a diagnosis of MDD, a Hamilton Depression Rating Scale (21-item version) score ≥15, no response to an antidepressant trial in the current depressive episode and treatment with a SSRI for a minimum of four weeks before study enrolment. Participants were allocated (1:1) by fixed-block randomization either to receive 30 min of 2mA bifrontal tDCS every weekday for 4 weeks, then two tDCS sessions per week for 2 weeks, or sham stimulation at the same intervals.

Primary outcome:

Change on the Montgomery- Åsberg Depression Rating Scale (MADRS) at week 6.

Trial registration:

ClinicalTrials.gov (NCT02530164)

Additional Materials:

https://osf.io/cpw6f/overview

Funding

The DepressionDC trial was conducted as part of the German Center for Brain Stimulation research consortium, which is
funded by the German Federal Ministry of Education and Research
(FKZ 01EE1403G).

Trial registration: DRKS00013764 Keywords: depression, trial, randomization

Publications & Media

Scientific papers

2026

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Cross-trial prediction of treatment response to transcranial direct current stimulation in patients with major depressive disorder

Burkhardt G, Goerigk S, Bulubas L and 18 more

Journal article 10.1016/j.pnpbp.2025.111600 Open

The British Journal of Psychiatry

Efficacy of transcranial direct current stimulation for depression: individual patient data meta-analysis

Razza LB, Luethi MS, Moffa A and 16 more

Journal article 10.1192/bjp.2025.10511 Open
2024

European Archives of Psychiatry and Clinical Neuroscience

Neurocognitive function as outcome and predictor for prefrontal transcranial direct current stimulation in major depressive disorder: an analysis from the DepressionDC trial

Soldini A, Vogelmann U, Aust S and 12 more

Journal article 10.1007/s00406-024-01759-2 Open
2023

Psychiatry Research

Adverse childhood experiences and clinical effects of transcranial direct current stimulation in major depressive disorder: Results from the DepressionDC trial

Burkhardt G, Goerigk S, Bulubas L and 22 more

Journal article 10.1016/j.psychres.2023.115577 Open

Frontiers in Psychiatry

Driving-related cognitive skills during antidepressant transcranial direct current stimulation: results in a subsample from the DepressionDC trial

Burkhardt G, Goerigk S, Dechantsreiter E and 7 more

Journal article 10.3389/fpsyt.2023.1255415 Open

The Lancet

Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial

Burkhardt G, Kumpf U, Crispin A and 29 more

Journal article 10.1016/s0140-6736(23)00640-2 Open

Press coverage

2025

Spektrum.de

Sanfter Strom gegen Depressionen

Spektrum.de

Einfach, schonend und relativ kostengünstig: Die transkranielle Gleichstromstimulation (tDCS) zur Therapie einer Depression kann problemlos zu Hause durchgeführt werden. Aber hilft sie auch?

Germany 23 Mar 2025 Read

The Guardian

Is a brain-stimulation headset the answer to depression?

David Cox

The makers of a device that delivers small electrical impulses to the brain are hailing the technology as a groundbreaking mental health treatment, but others are sceptical

11 Jan 2025 Read
2023

Gelbe Liste

DGPPN 2023: Kein Effekt der tDCS bei Antidepressivatherapie

Friederike Klein

Bisherige Studien zur tDCS bei Depression waren durch Gruppengröße, unterschiedliche Einschlusskriterien und verschiedene Stimulationsbedingungen in ihrer Aussagekraft eingeschränkt. Eine multizentrische Studie sollte mehr Evidenz liefern.

Germany 14 Dec 2023 Read

Klinikum der Universität München

Nicht-invasive Hirnstimulationsverfahren zur Behandlung der Depression

Burkhardt G

Nicht-invasive Hirnstimulationsverfahren zur Behandlung der Depression - neue Studie in der Fachzeitschrift The Lancet

Munich 12 Jul 2023 Read

Dashboard DepressionDC

Aggregated data · as of 2026-11-13

Groups

Groups

View aggregate values
Groups — aggregate values
Category Count Percent
shamtdcs 77 48.12%
activetdcs 83 51.88%

Sex distribution

Sex distribution

View aggregate values
Sex distribution — aggregate values
Category Percent
female 57.5%
male 42.5%
other 0.0%

Study structure

1 arm · 14 events · 22 instruments · 210 variables · saved state from 12 Nov 2026

Get the current state

Variables are shown to signed-in users. Sign in

Event Screening 14 instruments
Instrument Coversheet 6 variables
Instrument Demography 8 variables
Instrument Medical and Psychiatric History 19 variables
Instrument Physical Examination 24 variables
Instrument Vital Signs 7 variables
Instrument Smoking Status 4 variables
Instrument Assessments: EHI; HDRS-21 5 variables
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument Current Treatment: SSRI 3 variables
Instrument Current Treatment: Psychotherapy 4 variables
Instrument Current Treatment: Brain Stimulation 3 variables
Instrument Antidepressant Treatment History Form (ATHF) 11 variables
Event Inclusion/ Exclusion Criteria 0 instruments

No instruments in this event.

Event Baseline 8 instruments
Instrument Vital Signs 7 variables
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument Assessments: CTQ; SNI; CD-RISC 14 variables
Instrument Assessments: SHAPS-D; STAI; CGI-S; GAF; SF-36 27 variables
Instrument Assessments: WHO-DAS; BSI-53; WHO-5 9 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 1 6 instruments
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument tDCS Treatment Worksheet 9 variables
Instrument Blinding Check 3 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 2 6 instruments
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument tDCS Treatment Worksheet 9 variables
Instrument Blinding Check 3 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 3 6 instruments
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument tDCS Treatment Worksheet 9 variables
Instrument Blinding Check 3 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 4 8 instruments
Instrument Vital Signs 7 variables
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument Assessments: SHAPS-D; STAI; CGI-S; GAF; SF-36 27 variables
Instrument tDCS Treatment Worksheet 9 variables
Instrument Blinding Check 3 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 5 6 instruments
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument tDCS Treatment Worksheet 9 variables
Instrument Blinding Check 3 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 6 9 instruments
Instrument Physical Examination 24 variables
Instrument Vital Signs 7 variables
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: C-SSRS 4 variables
Instrument Assessments: SHAPS-D; STAI; CGI-S; GAF; SF-36 27 variables
Instrument tDCS Treatment Worksheet 9 variables
Instrument Blinding Check 3 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 18 - Follow-Up 4 instruments
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: SHAPS-D; STAI; CGI-S; GAF; SF-36 27 variables
Instrument Concomitant Psychotherapy 4 variables
Event Week 30 - Follow-Up 4 instruments
Instrument Assessments: MADRS 13 variables
Instrument Assessments: BDI-II 4 variables
Instrument Assessments: SHAPS-D; STAI; CGI-S; GAF; SF-36 27 variables
Instrument Concomitant Psychotherapy 4 variables
Event CM/AE 1 instrument
Instrument Adverse Event 14 variables
Event End of study 1 instrument
Instrument End Of Study 15 variables
Event Protocol Violations 0 instruments

No instruments in this event.

Last updated 11 Nov 2026 · Metadata harvested 12 Nov 2026